Literature DB >> 19895667

Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism.

Zheng-Xiong Xi1, Xia Li, Xiao-Qing Peng, Jie Li, Lauren Chun, Eliot L Gardner, Ajit G Thomas, Barbara S Slusher, Charles R Ashby.   

Abstract

Pharmacological activation of group II metabotropic glutamate receptors (mGluR2/3) inhibits cocaine self-administration and reinstatement of drug-seeking behavior, suggesting a possible use of mGluR2/3 agonists in the treatment of cocaine dependence. In this study, we investigated whether elevation of the endogenous mGluR2/3 ligand N-acetyl-aspartatylglutamate (NAAG) levels by the N-acetylated-alpha-linked-acidic dipeptidase inhibitor 2-(phosphonomethyl)pentanedioic acid (2-PMPA) attenuates cocaine self-administration and cocaine-induced reinstatement of drug seeking. N-acetylated-alpha-linked-acidic dipeptidase is a NAAG degradation enzyme that hydrolyzes NAAG to N-acetylaspartate and glutamate. Systemic administration of 2-PMPA (10-100 mg/kg, i.p.) inhibited intravenous self-administration maintained by low unit doses of cocaine and cocaine (but not sucrose)-induced reinstatement of drug-seeking behavior. Microinjections of 2-PMPA (3-5 microg/side) or NAAG (3-5 microg/side) into the nucleus accumbens (NAc), but not into the dorsal striatum, also inhibited cocaine-induced reinstatement, an effect that was blocked by intra-NAc injection of LY341495, a selective mGluR2/3 antagonist. In vivo microdialysis demonstrated that 2-PMPA (10-100 mg/kg, i.p.) produced a dose-dependent reduction in both extracellular dopamine (DA) and glutamate, an effect that was also blocked by LY341495. Finally, pre-treatment with 2-PMPA partially attenuated cocaine-enhanced extracellular NAc DA, while completely blocking cocaine-enhanced extracellular NAc glutamate in rats during reinstatement testing. Intra-NAc perfusion of LY341495 blocked 2-PMPA-induced reductions in cocaine-enhanced extracellular NAc glutamate, but not DA. These findings suggest that 2-PMPA is effective in attenuating cocaine-induced reinstatement of drug-seeking behavior, likely by attenuating cocaine-induced increases in NAc DA and glutamate via pre-synaptic mGluR2/3s.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895667      PMCID: PMC2809121          DOI: 10.1111/j.1471-4159.2009.06478.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  48 in total

1.  Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.

Authors:  T V Khroyan; R L Barrett-Larimore; J K Rowlett; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

2.  Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-alpha-linked-acidic dipeptidase (NAALADASE).

Authors:  B S Slusher; A Thomas; M Paul; C A Schad; C R Ashby
Journal:  Synapse       Date:  2001-07       Impact factor: 2.562

3.  (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.

Authors:  Iván Collado; Concepción Pedregal; Angel Mazón; Juan Félix Espinosa; Jaime Blanco-Urgoiti; Darryle D Schoepp; Rebecca A Wright; Bryan G Johnson; Ann E Kingston
Journal:  J Med Chem       Date:  2002-08-15       Impact factor: 7.446

4.  Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.

Authors:  Stanislav R Vorel; Charles R Ashby; Mousumi Paul; Xinhe Liu; Robert Hayes; Jim J Hagan; Derek N Middlemiss; Geoffrey Stemp; Eliot L Gardner
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

5.  Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.

Authors:  B S Slusher; J J Vornov; A G Thomas; P D Hurn; I Harukuni; A Bhardwaj; R J Traystman; M B Robinson; P Britton; X C Lu; F C Tortella; K M Wozniak; M Yudkoff; B M Potter; P F Jackson
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

Review 6.  N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system.

Authors:  J H Neale; T Bzdega; B Wroblewska
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

7.  Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction.

Authors:  J L Cornish; P W Kalivas
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

8.  Modulation of behavioral sensitization to cocaine by NAALADase inhibition.

Authors:  T S Shippenberg; W Rea; B S Slusher
Journal:  Synapse       Date:  2000-11       Impact factor: 2.562

9.  NAALADase (GCP II) inhibition prevents cocaine-kindled seizures.

Authors:  Jeffrey M Witkin; Maciej Gasior; Christina Schad; Agustin Zapata; Toni Shippenberg; Theresa Hartman; Barbara S Slusher
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

10.  Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior.

Authors:  P Di Ciano; B J Everitt
Journal:  Neuropsychopharmacology       Date:  2001-09       Impact factor: 7.853

View more
  35 in total

1.  Activation of mGluR7s inhibits cocaine-induced reinstatement of drug-seeking behavior by a nucleus accumbens glutamate-mGluR2/3 mechanism in rats.

Authors:  Xia Li; Jie Li; Eliot L Gardner; Zheng-Xiong Xi
Journal:  J Neurochem       Date:  2010-06-08       Impact factor: 5.372

Review 2.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

Review 3.  Addiction and brain reward and antireward pathways.

Authors:  Eliot L Gardner
Journal:  Adv Psychosom Med       Date:  2011-04-19

4.  Deletion of Type 2 Metabotropic Glutamate Receptor Decreases Sensitivity to Cocaine Reward in Rats.

Authors:  Hong-Ju Yang; Hai-Ying Zhang; Guo-Hua Bi; Yi He; Jun-Tao Gao; Zheng-Xiong Xi
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

5.  MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.

Authors:  Diana V Atigari; Rajendra Uprety; Gavril W Pasternak; Susruta Majumdar; Bronwyn M Kivell
Journal:  Neuropharmacology       Date:  2019-02-13       Impact factor: 5.250

Review 6.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 7.  Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer.

Authors:  C Bařinka; C Rojas; B Slusher; M Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 8.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

9.  Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme.

Authors:  Jesse Alt; Marigo Stathis; Camilo Rojas; Barbara Slusher
Journal:  FASEB J       Date:  2013-03-23       Impact factor: 5.191

10.  Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats.

Authors:  Xiao-Qing Peng; Jie Li; Eliot L Gardner; Charles R Ashby; Ajit Thomas; Krystyna Wozniak; Barbara S Slusher; Zheng-Xiong Xi
Journal:  Eur J Pharmacol       Date:  2009-10-31       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.